| Brattleboro Retreat | |
|
1 Anna Marsh Lane Brattleboro VT 05302-0803 | |
| (802) 257-7785 | |
| (802) 258-3723 |
| Full Name | Brattleboro Retreat |
|---|---|
| Speciality | Psychiatric Hospital |
| Location | 1 Anna Marsh Lane, Brattleboro, Vermont |
| Authorized Official Name and Position | Doreen Rancourt (CREDENTIALING) |
| Authorized Official Contact | 8022586956 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Brattleboro Retreat Po Box 101 Brattleboro VT 05302-0101 Ph: (802) 257-7785 | Brattleboro Retreat 1 Anna Marsh Lane Brattleboro VT 05302-0803 Ph: (802) 257-7785 |
| NPI Number | 1730185232 |
|---|---|
| Provider Enumeration Date | 06/21/2005 |
| Last Update Date | 11/02/2023 |
| Certification Date | 11/02/2023 |
| Medicare PECOS PAC ID | 7012828908 |
|---|---|
| Medicare Enrollment ID | O20041123000627 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1730185232 | NPI | - | NPPES |
| 0474001 | Medicaid | VT |
| Provider Name | Richard A Marasa |
|---|---|
| Provider Type | Practitioner - Emergency Medicine |
| Provider Identifiers | NPI Number: 1174518708 PECOS PAC ID: 8123922366 Enrollment ID: I20031120000484 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Timothy Larosa |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1063409985 PECOS PAC ID: 3274437033 Enrollment ID: I20031122000103 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Geoffrey P Kane |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1780671719 PECOS PAC ID: 0446242267 Enrollment ID: I20040401000552 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Hannah S Powell |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1932294261 PECOS PAC ID: 3577545581 Enrollment ID: I20040603000685 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Desiree Biesheuvel |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1629066352 PECOS PAC ID: 2961481510 Enrollment ID: I20040716000524 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Thomas R Hoskins |
|---|---|
| Provider Type | Practitioner - General Practice |
| Provider Identifiers | NPI Number: 1275565863 PECOS PAC ID: 7719957315 Enrollment ID: I20040730000104 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Sarah K Dudley |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1265545602 PECOS PAC ID: 2860420262 Enrollment ID: I20050727000866 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Magdalena R Naylor |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1184715294 PECOS PAC ID: 8426066150 Enrollment ID: I20060322000498 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Heidi Peterson |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1770687220 PECOS PAC ID: 6002824018 Enrollment ID: I20060403000621 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Christine C Gooley |
|---|---|
| Provider Type | Practitioner - Certified Clinical Nurse Specialist (cns) |
| Provider Identifiers | NPI Number: 1225112188 PECOS PAC ID: 3971514928 Enrollment ID: I20060505000534 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Marc R Laurens |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1477506681 PECOS PAC ID: 8325059090 Enrollment ID: I20060509000540 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Kurt L White |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1023111473 PECOS PAC ID: 4587672142 Enrollment ID: I20060929000369 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Jilisa Snyder |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1962436527 PECOS PAC ID: 3971662909 Enrollment ID: I20081106000037 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Elizabeth H Joseph |
|---|---|
| Provider Type | Practitioner - Osteopathic Manipulative Medicine |
| Provider Identifiers | NPI Number: 1427278456 PECOS PAC ID: 5799836748 Enrollment ID: I20090702000198 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Brianna Lu Seaver |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1902074677 PECOS PAC ID: 6709928658 Enrollment ID: I20100115000318 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Susanna L Woods |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1568482248 PECOS PAC ID: 8426043126 Enrollment ID: I20100303000468 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Cory Michael Nohl |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1184880569 PECOS PAC ID: 9638361082 Enrollment ID: I20101005000037 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Jeffrey M Haines |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1972523660 PECOS PAC ID: 8022093558 Enrollment ID: I20101110000305 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Mark Anagnostopulos |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1326252990 PECOS PAC ID: 0244419869 Enrollment ID: I20110127000640 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Lisa A Lambert |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1215915368 PECOS PAC ID: 9234180142 Enrollment ID: I20110215000285 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Marjorie J Smith |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1083683239 PECOS PAC ID: 8123013554 Enrollment ID: I20110725000184 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Militza Mizray |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1902016827 PECOS PAC ID: 7719908045 Enrollment ID: I20110929000072 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Jennifer L Fyler |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1538194089 PECOS PAC ID: 0547432361 Enrollment ID: I20111020000055 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Amelia G Shillingford |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1164711834 PECOS PAC ID: 9032383211 Enrollment ID: I20111128000535 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | William Knorr |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1922095967 PECOS PAC ID: 6305011560 Enrollment ID: I20111216000219 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Mark Rj Mcgee |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1598931156 PECOS PAC ID: 5991963761 Enrollment ID: I20120224000383 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Karl Jeffries |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1922282938 PECOS PAC ID: 8527235621 Enrollment ID: I20130318000337 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Lance B Thigpen |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1386739209 PECOS PAC ID: 0143210054 Enrollment ID: I20130515000493 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Amy Thomas |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1194754796 PECOS PAC ID: 0042273781 Enrollment ID: I20130821000652 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Martha M Coetzee |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1215914593 PECOS PAC ID: 6608915467 Enrollment ID: I20131118000344 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Heather J Palmer |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1851718241 PECOS PAC ID: 5496979080 Enrollment ID: I20140623001314 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Tracey E Krasnow |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1740499656 PECOS PAC ID: 1951440767 Enrollment ID: I20140630001647 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Simha Ravven |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1629210281 PECOS PAC ID: 5799905402 Enrollment ID: I20141001000861 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | James M Benton |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1881073187 PECOS PAC ID: 3870807225 Enrollment ID: I20150730010607 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | John H Fanton |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1881783397 PECOS PAC ID: 9133196389 Enrollment ID: I20150807014259 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Susan F Balaban |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1447616834 PECOS PAC ID: 2668777129 Enrollment ID: I20160219002094 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Catherine Mattei Williams |
|---|---|
| Provider Type | Practitioner - Certified Clinical Nurse Specialist (cns) |
| Provider Identifiers | NPI Number: 1982791364 PECOS PAC ID: 9830377373 Enrollment ID: I20160516001910 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Jerry A Jacobs |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1770850505 PECOS PAC ID: 8527381284 Enrollment ID: I20160614000077 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Milangel T Concepcion Zayas |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1407147564 PECOS PAC ID: 8426344094 Enrollment ID: I20160907002494 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Patricia A Dille |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1730516782 PECOS PAC ID: 4688896574 Enrollment ID: I20160927001155 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Marcialee Ledbetter |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1164492567 PECOS PAC ID: 0840288445 Enrollment ID: I20170103000392 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Adnan S Khan |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1245363761 PECOS PAC ID: 9032202064 Enrollment ID: I20170106000042 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Laura J Kelloway |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1861692303 PECOS PAC ID: 3779866405 Enrollment ID: I20170203000864 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Judy Katz |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1376089771 PECOS PAC ID: 3577847698 Enrollment ID: I20170308001903 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Johanna Murphy |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1558809046 PECOS PAC ID: 0446524078 Enrollment ID: I20170921000330 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Alan Kyle Hagstrom |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1619947801 PECOS PAC ID: 5991959207 Enrollment ID: I20171005003580 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Mona C Daye |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1619140316 PECOS PAC ID: 3072640085 Enrollment ID: I20171212000551 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Mary F Canale |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1205279304 PECOS PAC ID: 7618106105 Enrollment ID: I20171213000619 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Alvin Fineman |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1497826051 PECOS PAC ID: 5597753202 Enrollment ID: I20180102001256 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Barbara C Pottinger |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1194135335 PECOS PAC ID: 1355561200 Enrollment ID: I20180112000656 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Stephanie Ann Cryer |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1679087977 PECOS PAC ID: 8123387826 Enrollment ID: I20180125000216 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Jarred C Zucker |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1215249560 PECOS PAC ID: 2264792266 Enrollment ID: I20180213001919 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Moddy H Kiluvia |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1922073261 PECOS PAC ID: 4486849411 Enrollment ID: I20180213002381 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Lisa Tallin |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1821506155 PECOS PAC ID: 3173885076 Enrollment ID: I20180312001874 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | William L Burch |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1760693691 PECOS PAC ID: 4284700543 Enrollment ID: I20180315000740 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Anna May Seaver |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1477842185 PECOS PAC ID: 6800151895 Enrollment ID: I20180522001019 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Ergi O Gumusaneli |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1225283260 PECOS PAC ID: 7315186251 Enrollment ID: I20180718001874 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Philip B Laplante |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1881099950 PECOS PAC ID: 9537416870 Enrollment ID: I20180718002079 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Adam J Pruett |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1609050756 PECOS PAC ID: 7315079563 Enrollment ID: I20180813002462 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Mark J Cerbone |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1497708671 PECOS PAC ID: 3678605292 Enrollment ID: I20180907000256 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Susan M Fields |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1528247509 PECOS PAC ID: 8123370897 Enrollment ID: I20181008001087 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Matthew Dove |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1124538814 PECOS PAC ID: 3971855545 Enrollment ID: I20181009002459 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Amy J Laurent |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1073670659 PECOS PAC ID: 1951499557 Enrollment ID: I20181010002840 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Peter B Kassis |
|---|---|
| Provider Type | Practitioner - Addiction Medicine |
| Provider Identifiers | NPI Number: 1962416982 PECOS PAC ID: 1355379835 Enrollment ID: I20181206003106 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | John E Omalley |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1811996200 PECOS PAC ID: 6406154491 Enrollment ID: I20181220003056 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Sarah J Grosse |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1225020258 PECOS PAC ID: 1052376258 Enrollment ID: I20190201002499 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Christine A Miller |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1205859485 PECOS PAC ID: 2567709215 Enrollment ID: I20190204000829 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Viorika Nelson |
|---|---|
| Provider Type | Practitioner - Certified Clinical Nurse Specialist (cns) |
| Provider Identifiers | NPI Number: 1760422612 PECOS PAC ID: 4082674205 Enrollment ID: I20190212001903 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Jason A Wilson |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1437473998 PECOS PAC ID: 8820120553 Enrollment ID: I20190212002098 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Jason M Schmotzer |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1295771038 PECOS PAC ID: 1759394372 Enrollment ID: I20190221001956 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Jaime Stevens |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1710286489 PECOS PAC ID: 7517271612 Enrollment ID: I20190403000204 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Timothy L Kanczuga |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1295282598 PECOS PAC ID: 0840533568 Enrollment ID: I20190521003002 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | John-paul Cloutier |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1205492196 PECOS PAC ID: 9638405434 Enrollment ID: I20190801000624 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Luke D Miller |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1174939797 PECOS PAC ID: 8628359940 Enrollment ID: I20190822000131 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Marissa L Martin |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1497137277 PECOS PAC ID: 8729316989 Enrollment ID: I20190826002492 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Alfred S Goldyne |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1679817498 PECOS PAC ID: 9739428046 Enrollment ID: I20191017001282 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Colin A Polnitsky |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1073819819 PECOS PAC ID: 8022441393 Enrollment ID: I20191129000190 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Jon Cariker |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1861915795 PECOS PAC ID: 1951637024 Enrollment ID: I20200115002065 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Clarissa Juarez |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1225471154 PECOS PAC ID: 3971743675 Enrollment ID: I20200130001412 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Lindsey M Weaver |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1831741933 PECOS PAC ID: 9133555287 Enrollment ID: I20200207001954 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Robin K Caron |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1396006698 PECOS PAC ID: 2365740818 Enrollment ID: I20200330000713 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Lindsey V Coward |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1407348675 PECOS PAC ID: 3072855360 Enrollment ID: I20200526002531 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Rhonda K Long |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1538286315 PECOS PAC ID: 1951682020 Enrollment ID: I20200604001712 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Cindy M Mcdonough |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1447289533 PECOS PAC ID: 9830126523 Enrollment ID: I20200609001351 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Deborah Hoenig |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1508222019 PECOS PAC ID: 6608171632 Enrollment ID: I20200817000300 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Julie Tracy-prieboy |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1356773659 PECOS PAC ID: 8022434463 Enrollment ID: I20200817002366 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Kara Dibble |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1356904817 PECOS PAC ID: 8729493382 Enrollment ID: I20210213000021 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Jessica Shepley |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1043706419 PECOS PAC ID: 4587068630 Enrollment ID: I20210811002053 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Gwynn Yandow |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1073133831 PECOS PAC ID: 7214332493 Enrollment ID: I20210826000674 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Rachael Kandath |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1215383732 PECOS PAC ID: 9830432699 Enrollment ID: I20210831002112 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Susan M Plante |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1770681611 PECOS PAC ID: 2264501220 Enrollment ID: I20210902001416 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Scott D Robinson |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1235625294 PECOS PAC ID: 8426307778 Enrollment ID: I20210913000646 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Katrina Marie Prive |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1679170922 PECOS PAC ID: 0345647418 Enrollment ID: I20210916002849 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Nicholas James Hurst |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1073855763 PECOS PAC ID: 6406160654 Enrollment ID: I20210930002946 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Carly Macken |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1790300291 PECOS PAC ID: 2062810799 Enrollment ID: I20211012000202 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Lydia Greene |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1568909851 PECOS PAC ID: 6608265871 Enrollment ID: I20211109000871 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Kelcy Wiley |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1508246695 PECOS PAC ID: 2860795804 Enrollment ID: I20211109002296 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Emma Cadman |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1588327985 PECOS PAC ID: 4587053780 Enrollment ID: I20211109002659 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Cynthia J Preis |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1932151271 PECOS PAC ID: 8325043417 Enrollment ID: I20220310001053 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Zachary Wigham |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1538569918 PECOS PAC ID: 1355726837 Enrollment ID: I20220920001084 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Jane M Worley |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1881682516 PECOS PAC ID: 7618036658 Enrollment ID: I20221209000861 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Patricia M Kijak |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1457073108 PECOS PAC ID: 6507236791 Enrollment ID: I20230104002293 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Heather Leonardy |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1366987299 PECOS PAC ID: 9830430446 Enrollment ID: I20230317001054 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Heather Barnett Veague |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1750631826 PECOS PAC ID: 5991160228 Enrollment ID: I20230420001322 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Rachel Owen |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1669025888 PECOS PAC ID: 1153651153 Enrollment ID: I20230428000862 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Adare A Yanagihara |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1871988238 PECOS PAC ID: 3476897141 Enrollment ID: I20230628001992 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Melanie C Clark |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1306272687 PECOS PAC ID: 0648405274 Enrollment ID: I20231012000109 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Jonathan D Beamer |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1578511218 PECOS PAC ID: 3678579539 Enrollment ID: I20231012003749 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Eliot G Desilva |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1538121439 PECOS PAC ID: 6901822279 Enrollment ID: I20231113001874 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Jessica P Tamulonis |
|---|---|
| Provider Type | Practitioner - Psychologist Billing Independently |
| Provider Identifiers | NPI Number: 1386351104 PECOS PAC ID: 9931370152 Enrollment ID: I20231209000750 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Chukwuka Sopulu Onubogu |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1568159325 PECOS PAC ID: 4587013834 Enrollment ID: I20231212001104 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Nerissa Russo |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1326449836 PECOS PAC ID: 3870943723 Enrollment ID: I20231219002101 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Betty Jane Tullius |
|---|---|
| Provider Type | Practitioner - Marriage And Family Therapist |
| Provider Identifiers | NPI Number: 1972616233 PECOS PAC ID: 3476903295 Enrollment ID: I20231220000757 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Sarah Catherine Kocz |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1356886691 PECOS PAC ID: 8921459132 Enrollment ID: I20240111002317 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Katelyn Mulford O'connor |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1275279457 PECOS PAC ID: 0840641973 Enrollment ID: I20240112001983 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Gina Victoria Pearce |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1174003354 PECOS PAC ID: 0547612442 Enrollment ID: I20240116003627 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Teresa R Butler |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1699843896 PECOS PAC ID: 8921450743 Enrollment ID: I20240117003252 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Darcy E Gingerich |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1669435079 PECOS PAC ID: 1658723218 Enrollment ID: I20240118003910 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Paul Dilonno |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1669692851 PECOS PAC ID: 2466877105 Enrollment ID: I20240119001701 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Jenny V Karstad |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1831599885 PECOS PAC ID: 7719108950 Enrollment ID: I20240124003077 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
| Provider Name | Steven Prentice |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1376856286 PECOS PAC ID: 3274775291 Enrollment ID: I20240313001027 |
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
News Archive
Researchers today presented and published results from the TRA-2P (Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) TIMI 50 study of vorapaxar, Merck's investigational anti-thrombotic medicine, in patients with a prior history of cardiovascular events or disease.
Governor Edward G. Rendell's proposed 2010-11 budget maintains essential health care and other safety net services during the economic recovery by better managing programs, attacking waste and reducing unnecessary spending.
Immigrants living less than five years in Canada are less likely than their Canadian-born counterparts to have premature babies regardless of where they live, according to a new study by St. Michael's Hospital.
Mylan Inc. today announced that the company's Mylan Pharmaceuticals and Matrix Laboratories subsidiaries entered into a settlement and license agreement with Pfizer Inc. relating to Voriconazole Tablets, 50 mg and 200 mg, the generic version of Pfizer's Vfend Tablets, a triazole antifungal agent.
› Verified 9 days ago
Innerwell Integrative Counseling Services L3c Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 262 Western Ave, Brattleboro, VT 05301 Phone: 802-231-2550 | |
Moon River Counseling Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 15 Homestead Pl, Brattleboro, VT 05301 Phone: 401-489-6463 | |
Springfield Hospital Psychiatry Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 38 Park Pl, Brattleboro, VT 05301 Phone: 802-857-2442 | |
Riggs Neuropsychology Associates, Pllc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 55 Marlboro Rd, Suite 11, Brattleboro, VT 05301 Phone: 802-275-8224 | |
Drift Mavyn Licsw Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 38 Park Pl, Brattleboro, VT 05301 Phone: 802-321-5066 Fax: 802-210-3972 | |
Richard Doucet Licsw Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 36 Park Pl Ste 101, Brattleboro, VT 05301 Phone: 802-246-1221 Fax: 802-246-1002 | |
Crescent Psychotherapy, Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 136b Prospect St, Brattleboro, VT 05301 Phone: 207-560-6033 |